|
Volumn 22, Issue 22, 2014, Pages 6459-6470
|
2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion
|
Author keywords
8 Amino imidazo 1,2 a pyrazine; ATPase inhibitor; Bacterial type IV secretion system; HP0525
|
Indexed keywords
2 AMINO 1 (2 NAPHTHYL)ETHANOL;
2 AZIDO 1 (2 NAPHTHYL)ETHANONE;
2 AZIDO 1 (2-NAPHTHYL)ETHANOL;
2 BROMO 1 (2 PHENOXYPHENYL)ETHANONE;
2 [(3 CHLOROPYRAZIN 2 YL)AMINO] 1 (2 NAPHTHYL)ETHANOL;
2 [(3 CHLOROPYRAZIN 2 YL)AMINO] 1 (2 NAPHTHYL)ETHANONE;
4 METHYL N [2 (2 NAPHTHYL)IMIDAZO[1,2 A]PYRAZINE 8 YL]BENZENESULFONAMIDE;
4 METHYL N [4 [2 (2 NAPHTHYL)IMIDAZO[1,2 A]PYRAZINE 8 YL]AMINOPHENYL]BENZENESULFONAMIDE;
4 METHYL N [4 [3 (2 NAPHTHYL)IMIDAZO[1,2 A]PYRAZINE 8 YL]AMINOPHENYL]BENZENESULFONAMIDE;
8 (METHYLSULFONYL) 2 (NAPHTHALEN 2 YL)IMIDAZO[1,2 A]PYRAZINE;
8 AMINO IMIDAZO[1,2 A]PYRAZINE DERIVATIVE;
8 CHLORO 2 (2 NAPHTHYL)IMIDAZO[1,2 A]PYRAZINE;
8 CHLORO 3 (2 NAPHTHYL)IMIDAZO[1,2 A]PYRAZINE;
ANTIINFECTIVE AGENT;
ENZYME INHIBITOR;
HP 0525;
PYRAZINE DERIVATIVE;
UNCLASSIFIED DRUG;
BACTERIAL PROTEIN;
IMIDAZO(1,2-A)PYRAZINE;
IMIDAZOLE DERIVATIVE;
PROTEIN BINDING;
ARTICLE;
BACTERIAL SECRETION SYSTEM;
BACTERIAL TYPE IV SECRETION;
CRYSTAL STRUCTURE;
DOSE RESPONSE;
DRUG POTENCY;
DRUG SOLUBILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HELICOBACTER PYLORI;
IC50;
MICHAELIS MENTEN KINETICS;
MOLECULAR DOCKING;
NONHUMAN;
PHYSICAL CHEMISTRY;
STEADY STATE;
STRUCTURE ACTIVITY RELATION;
ANTAGONISTS AND INHIBITORS;
BINDING SITE;
CHEMISTRY;
GRAM NEGATIVE BACTERIUM;
KINETICS;
METABOLISM;
PROTEIN TERTIARY STRUCTURE;
SYNTHESIS;
ANTI-BACTERIAL AGENTS;
BACTERIAL PROTEINS;
BINDING SITES;
GRAM-NEGATIVE BACTERIA;
IMIDAZOLES;
KINETICS;
MOLECULAR DOCKING SIMULATION;
PROTEIN BINDING;
PROTEIN STRUCTURE, TERTIARY;
PYRAZINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84908360366
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2014.09.036 Document Type: Article |
Times cited : (30)
|
References (44)
|